Blue lips and blue nail beds in a child usually mean one of two things, and both are urgent. Either the heart is failing to route blood properly, or the lungs are failing to oxygenate it. Cardiology and pulmonology get called, an echocardiogram gets ordered, and the search begins.
In a small number of patients, every one of those tests comes back normal, over and over, sometimes for years. The child is active, growing normally, and persistently blue.
The explanation is not in the heart or the lungs. It is a single amino acid substitution in the beta-globin chain of hemoglobin that produces a variant called hemoglobin M Hyde Park.
One Letter, Locked Iron
Normal hemoglobin carries iron in the ferrous state, which binds and releases oxygen. In hemoglobin M variants, a mutation stabilizes that iron in the ferric state instead. Ferric iron cannot carry oxygen. The result is methemoglobin, present at a fraction of a percent in everyone but elevated in these patients.
Hemoglobin M Hyde Park, also known as hemoglobin M Akita and hemoglobin Milwaukee-2, arises from a point mutation at codon 92 of the beta globin gene that swaps histidine for tyrosine. It is inherited in an autosomal dominant pattern, so a single copy is sufficient to produce the phenotype.
Clinically, most affected people are unremarkable apart from the color. A case series from a Malay family in Malaysia described a 9-year-old girl found to be cyanotic incidentally at a health clinic, with relatives diagnosed after family screening. Patients typically have mild hemolysis because the variant hemoglobin is unstable, with no functional limitation. A Korean family with the same variant came to attention only when a 16-year-old was referred for gallstone surgery; her mother and two brothers were also visibly cyanotic and otherwise well.
It can also appear with no family history, arising as a de novo mutation in a child whose parents both sequence normally.
The Machine Cannot See It
The most consequential feature of these variants is a diagnostic trap rather than a health risk.
Pulse oximeters work by assuming that only two forms of hemoglobin are present, oxyhemoglobin and deoxyhemoglobin, and by calculating a ratio of light absorption at two wavelengths. Methemoglobin and hemoglobin variants break that assumption, and readings become unreliable and stubbornly low.
Arterial blood gas analysis creates a second trap in the opposite direction. It measures dissolved oxygen in plasma, which is normal, and often reports a calculated saturation that looks reassuring. The mismatch between a low pulse oximetry reading and a normal arterial oxygen measurement is called a saturation gap, and recognizing it is often the diagnostic turning point.
Co-oximetry, which reads multiple wavelengths, can usually distinguish the abnormal species directly, though not always. In one reported case involving a related variant, two analyzers could not return a methemoglobin value due to spectral interference. Confirmation ultimately requires high-performance liquid chromatography and gene sequencing.
A neonatal case illustrates how deceptive the picture is. A newborn with cyanosis apparent from birth had stable respiratory and hemodynamic status and normal arterial oxygen saturation, but pulse oximetry readings that did not rise on 100 percent supplemental oxygen. Sequencing identified hemoglobin M Boston, a related alpha chain variant. Notably, the methemoglobin level measured by co-oximetry was normal, which the authors flag as a reason not to rule out hemoglobin M disease on that basis alone.
Where It Actually Matters
Because patients are usually asymptomatic, most reports conclude that no treatment is required. Methylene blue, the standard therapy for acquired methemoglobinemia from oxidizing drugs or chemicals, does not correct hemoglobin M variants.
The real stakes are procedural. Under general anesthesia, an anesthesiologist relies on pulse oximetry to detect hypoxia. In a patient whose baseline reading is falsely low, that monitor is not telling the truth, and a genuine desaturation could be missed or a normal state treated as an emergency. A published account of a laparoscopic myomectomy in a patient with hemoglobin M describes persistently low pulse oximetry readings throughout the procedure, and multiple reports emphasize that these patients require an anesthetist who is aware of the diagnosis in advance.
There is a second reason a benign finding deserves a name. In regions where beta thalassemia carriage is common, the Malaysian authors note a local carrier rate of roughly 3.5 to 4 percent, and offspring who inherit both a hemoglobin M variant and another beta-globin disorder can develop severe hemolytic anemia. That makes family screening and genetic counseling worthwhile, even when affected relatives feel perfectly well.
The broader lesson is diagnostic. Cyanosis that does not respond to oxygen, in a patient with a normal echocardiogram and normal chest imaging, should prompt evaluation of the blood itself. Acquired methemoglobinemia from oxidizing agents can be life-threatening and needs urgent treatment. The congenital hemoglobin variants generally do not. Telling them apart requires more than a pulse oximeter.
Anyone with unexplained bluish discoloration of the lips, fingers, or nail beds should be evaluated by a clinician, and sudden cyanosis with breathing difficulty is a medical emergency.
Key Questions Answered
What is hemoglobin M Hyde Park?
A rare inherited hemoglobin variant, caused by a point mutation at codon 92 of the beta globin gene, that locks heme iron in a form unable to carry oxygen.
Why does it turn skin blue?
The abnormal hemoglobin behaves like methemoglobin, which is dark in color and does not bind oxygen, producing visible cyanosis in lips, nail beds, and skin.
Is it dangerous?
Generally not. Most carriers are asymptomatic aside from cyanosis and mild hemolysis, and reports conclude that no treatment is needed.
Why do pulse oximeters give wrong readings?
Standard pulse oximetry assumes only oxyhemoglobin and deoxyhemoglobin are present. Abnormal hemoglobin species break that assumption and produce falsely low readings.
Does methylene blue treat it?
No. Methylene blue treats acquired methemoglobinemia caused by oxidizing agents. It does not correct structural hemoglobin variants.
Why does the diagnosis matter if patients are well?
Because pulse oximetry is unreliable during anesthesia in these patients, and because offspring who inherit an additional beta-globin disorder may develop severe anemia.
